Thioguanine Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20 mg, 25 mg, 40 mg
Reference Brands: Tabloid (USA), Lanvis (EU)
Category:
Oncology Cancer Care
Thioguanine is available in Tablets
and strengths such as 20 mg, 25 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Thioguanine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Thioguanine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Tioguanine, also known as thioguanine or 6-thioguanine (6-TG), is a chemotherapeutic medication primarily used to treat various types of leukemia, including acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), and chronic myeloid leukemia (CML). It belongs to the class of antimetabolite drugs and works by interfering with the synthesis of DNA and RNA in rapidly dividing cancer cells, thereby inhibiting their growth and proliferation.
Administered orally, tioguanine is often incorporated into treatment regimens for patients with leukemia, especially in cases where other therapies may be less effective or during maintenance therapy. Due to its potency and potential for toxicity, long-term use of tioguanine is generally not recommended, and careful monitoring of blood counts and liver function is essential during treatment. Side effects can include myelosuppression, liver toxicity, and gastrointestinal disturbances, emphasizing the need for close supervision by oncology specialists.
Tioguanine has played a significant role in leukemia management since its development and continues to be a valuable option for targeted chemotherapy. Its use requires precise dosing and regular monitoring to maximize therapeutic benefits while minimizing adverse effects, supporting improved outcomes for patients with hematologic malignancies.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing